Suppr超能文献

长期使用醋酸甲羟孕酮避孕者的骨矿物质密度

Bone mineral density in long-term depot medroxyprogesterone acetate acceptors.

作者信息

Taneepanichskul S, Intaraprasert S, Theppisai U, Chaturachinda K

机构信息

Department of Obstetrics and Gynaecology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

出版信息

Contraception. 1997 Jul;56(1):1-3. doi: 10.1016/s0010-7824(97)00066-8.

Abstract

The study of bone density in long-term DMPA users is reported. The aims were to study and compare bone density in long-term DMPA users with intrauterine device (IUD) users. Fifty current users of DMPA with a minimum 36 months previous use were compared to 50 current IUD users as control. The bone mineral density was measured by dual energy x-ray absorptiometry (DEXA) at the non-dominant distal and ultradistal forearm. Serum estradiol was measured by microparticle enzyme immunoassay technique in both groups. Age, income, weight, height, BMI, and parity of both groups were matched. The mean bone mineral density of distal forearm in DMPA and IUD users was 0.48 +/- 0.05 g/cm2 in both groups. The mean bone mineral density of ultradistal forearm was 0.38 +/- 0.06 g/cm2 in DMPA users and 0.4 +/- 0.05 g/cm2 in IUD users. No differences in mean bone mineral density of distal and ultradistal forearm between DMPA and IUD users was demonstrated (95% CI -0.02, 0.02 and -0.04, 0.001, respectively). However, the serum estradiol levels were significantly different between DMPA and IUD users (95% CI -122, -68.1). From this study, it is suggested that long-term DMPA use should not have any adverse effect on bone density even if it reduces serum estradiol.

摘要

本文报道了对长期使用醋酸甲羟孕酮(DMPA)的女性骨密度的研究。目的是研究并比较长期使用DMPA的女性与使用宫内节育器(IUD)的女性的骨密度。将50名既往至少使用过36个月DMPA的现使用者与50名现使用IUD的女性作为对照进行比较。采用双能X线吸收法(DEXA)测量非优势侧前臂远端和超远端的骨矿物质密度。两组均采用微粒酶免疫分析技术测定血清雌二醇。两组的年龄、收入、体重、身高、体重指数(BMI)和产次相匹配。DMPA组和IUD组的前臂远端平均骨矿物质密度均为0.48±0.05g/cm²。DMPA组前臂超远端平均骨矿物质密度为0.38±0.06g/cm²,IUD组为0.4±0.05g/cm²。DMPA组和IUD组在前臂远端和超远端的平均骨矿物质密度上未显示出差异(95%可信区间分别为-0.02,0.02和-0.04,0.001)。然而,DMPA组和IUD组的血清雌二醇水平存在显著差异(95%可信区间为-122,-68.1)。从本研究来看,提示长期使用DMPA即使会降低血清雌二醇水平,也不会对骨密度产生任何不良影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验